GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
29 sept. 2020 14h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Sept. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies...